Previous 10 | Next 10 |
All Microbiome Services to be Unified under the Diversigen Brand BETHLEHEM, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, to...
Image source: The Motley Fool. OraSure Technologies (NASDAQ: OSUR) Q1 2020 Earnings Call May 06, 2020 , 5:00 p.m. ET Operator Continue reading
OraSure Technologies, Inc. (OSUR) Q1 2020 Earnings Conference Call May 06, 2020, 17:00 ET Company Participants Stephen Tang - President, CEO & Director Roberto Cuca - CFO & Principal Accounting Officer Conference Call Participants Jacob Johnson - Stephens Inc. Andre...
OraSure Technologies (NASDAQ: OSUR ): Q1 GAAP EPS of -$0.12 misses by $0.06 . More news on: OraSure Technologies, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
BETHLEHEM, Pa., May 06, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices and microbiome laboratory and analytical services, today announced its financial results for the three months ended March 31, 2...
BETHLEHEM, Pa., May 05, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that Lisa Nibauer has been appointed Executive Vice Preside...
OTTAWA, May 04, 2020 (GLOBE NEWSWIRE) -- DNA Genotek Inc., a leading provider of sample collection kits and end-to-end services and a wholly-owned subsidiary of OraSure Technologies, Inc. (NASDAQ: OSUR), announced today that its ORAcollect®·RNA kit (OR-100) was included as the col...
A recently completed study conducted by Accurate Diagnostics Labs and joint venture partner RUCDR Infinite Biologics at Rutgers University demonstrated the potential use of saliva samples to test for SARS-CoV-2, the virus causing COVID-19. More news on: Abbott Laboratories, Roche Holding...
BETHLEHEM, Pa., April 08, 2020 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the appointment of David J. Shulkin, M.D., as a member of...
OraSure Technologies (NASDAQ: OSUR ) has been awarded a $710,310 contract from the Biomedical Advanced Research and Development Authority (BARDA) to develop a pan-SARS-coronavirus antigen rapid in-home self-test that uses oral fluid samples and provides results in 20 minutes. More news o...
News, Short Squeeze, Breakout and More Instantly...
OraSure Technologies Inc. Company Name:
OSUR Stock Symbol:
NASDAQ Market:
OraSure Technologies Inc. Website:
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024. A webcast of the conference call w...
2024-07-02 09:00:08 ET Vijay Kumar from Evercore ISI issued a price target of $4.50 for OSUR on 2024-07-02 08:07:00. The adjusted price target was set to $4.50. At the time of the announcement, OSUR was trading at $4.27. OSUR currently trades -49.59% versus its 52 week h...
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Tes...